Bharat Parenterals Ltd reports Q2 FY27 consolidated revenue of ₹136.28 crore and net profit of ₹11.82 crore
- Revenue rose 110.9% year on year and 45.4% sequentially.
- EBITDA margin improved to 17.3%, from 1.3% in Q2 FY26 and 9.1% in Q1 FY27.
- Board approved unaudited results and MD&A; auditors’ limited reviews noted no material misstatement or required disclosure omissions.